APHON is committed to excellence in pediatric hematology/oncology nursing practice. This is accomplished by members and colleagues teaching one another current trends and new information, as well as learning from and sharing previous experiences.
Learning Outcomes
APHON is an accredited provider of continuing nursing education (CNE) with the American Nurses Credentialing Center (ANCC) and is responsible for developing and evaluating individual educational activities in compliance with current ANCC Accreditation Program criteria. With this in mind, the Annual Conference Planning committee designed this program to address the following identified learning gaps in knowledge, skills and practice:
This conference is designed to address the following identified learning gaps in knowledge, skills, and practice:
Hematology
Red Cell Disorders (Sickle Cell Disease, Thalassemia) | Platelet disorders (ITP, Platelet Function Defects) | Bleeding disorders (Hemophilia, Von Willebrand Disease) | Thrombosis/Clotting | Vascular Malformations | Aplastic Anemia and Bone Marrow Failure
Oncology
Solid Non-CNS Tumors | Hematologic malignancies (Leukemia, Lymphoma) | CNS tumors|Oncologic Complications/Emergencies | Histiocytic Disorders (LCH and HLH) | End of Therapy/Completion of Treatment
Cellular Therapies
Hematopoietic Stem Cell Transplant | Post HSCT Complications and Management (GVHD, SOS, Graft Rejection) | Stem Cell Transplant for Nonmalignant Disorders | CAR-T|CRISPR
Supportive Care/Symptom Management
Pain Management | Integrative Medicine | Complementary and Alternative Therapies | Transfusion Therapy/Blood Utilization | Infection Control/Prophylaxis/CLABS I | Nutritional Support
Fertility Preservation | Survivorship/Late Effects | End of Life/Palliative Care
Adolescent/Young Adult (AYA)
Developmental Considerations | Incorporation of AYA in Pediatric Programs | Program Development | Transition to Adult Care
Psychosocial
Distress Assessment/Management | Mental/Emotional Support | Ethical Considerations | Adherence | Cultural Implications
Chemotherapy/Biotherapy/Pharmacology
Phase 1 and 2 Clinical Trials | Molecular Guided Therapy | Biotherapy/Immunotherapy | Targeted Therapy | USP 800
General Clinical Practice
Genetics (General Principles, Diagnostic/Prognostic/Therapeutic Implications) | Disease-Related Biology | Radiology/Imaging | Radiation Therapy
Advanced Practice
Clinical Pearls and Tips | Diagnostic Dilemmas | Procedure Training and Competency | Prescribing Practices | Professional Practice | Scope of Practice Boundaries | Pharmacology | Opioid Prescribing Challenges | Documentation of Outcomes | Critical Conversations
Nursing Practice
Emotional Intelligence | Evidence-Based Practice | Quality Improvement | Standards for Care | Self-Care/Resiliency | Professional Boundaries|Legislative Updates | Generational Differences in Nurses | Mentoring
Nurse Education and Professional Development
Adult Learning Principles | Orientation for RNs and APNs | NP Residency/Fellowship Programs | Leadership at All Levels of Practice | Professional Writing for Grants, Abstracts or Journals/Publications | Creating Professional Presentations
Management/Administration
Healthcare Updates and Policies | Team Building | Staffing and Acuity | Conflict Management
Description of Current State
Pediatric Hematology/Oncology Nursing is a continuously evolving field of practice, but many nurses report they are challenged to keep up with new and innovative therapies, current trends in hematology/oncology/cellular therapies, and other aspects of care.
Description of Desired/Achievable State
Pediatric Hematology/Oncology nurses need to have the knowledge, skills, and the ability to apply new information learned as they care for their patients, families, and themselves.
The learning outcomes for the 2019 Annual Conference are the following:
Learning Outcome 1:
The learner will be able to incorporate or identify strategies essential for managing the challenges facing pediatric hematology/oncology nurses and the patients we serve.
Learning Outcome 2:
The learner will demonstrate increased knowledge related to the care of children, adolescents and young adults with hematologic or oncologic disorders while implementing self-care strategies.
The measurement of these outcomes will be evidenced by pre and post testing as well as the results of 30, 60 and 90-day surveys.
